Mesenchymal Stem Cell-Hydrogel Composition for Anal Fistula Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for anal fistulas, including traditional surgeries and minimally invasive methods, face challenges such as high recurrence rates, sphincter damage, and prolonged recovery times, with existing stem cell treatments limited by the need for multiple surgeries and ethical concerns.
Innovation Solution
A composition comprising mesenchymal stem cells dispersed within a hydrogel, which can be injected into the fistula site, enhancing therapeutic effects and reducing surgical frequency and discomfort.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional surgical methods are used to treat anal fistulas, then the fistula can be sealed, but the surgical pain is severe and postoperative wound healing is slow
Solution Approach 1:
The hydrogel is pre-loaded with mesenchymal stem cells and prepared in advance before injection. The stem cells are cultured and expanded ex vivo, then encapsulated in the hydrogel matrix prior to surgical implantation, allowing the therapeutic agent to be ready for immediate use during the minimally invasive procedure
Solution Approach 2:
The hydrogel serves as an intermediary carrier that delivers mesenchymal stem cells to the fistula site. The hydrogel matrix protects the stem cells during transplantation and provides a controlled release system, mediating between the stem cells and the damaged tissue to enhance healing while reducing surgical trauma
2Reliability
If traditional surgical methods are used to treat anal fistulas, then the fistula tract can be cleared, but the incidence of anal incontinence is high due to sphincter damage
Solution Approach 1:
The invention extracts the essential therapeutic function (stem cell delivery) from traditional surgical removal methods. Instead of surgically removing and clearing the fistula tract with extensive tissue removal, the hydrogel with stem cells is injected to promote biological healing, extracting only the necessary therapeutic action while avoiding harmful surgical intervention
Solution Approach 2:
The mesenchymal stem cells within the hydrogel perform self-service by autonomously differentiating into tissue cells and secreting regenerative factors at the fistula site. The cells self-organize to repair the tract and regenerate tissue without requiring continuous external intervention or aggressive surgical clearance
3Object-affected harmful factors
If minimally invasive surgical techniques are used, then surgical pain is reduced and sphincter function is protected, but the recurrence rate remains relatively high
Solution Approach 1:
The hydrogel provides continuous delivery of mesenchymal stem cells to the fistula site over an extended period. The sustained release system maintains a constant therapeutic concentration, ensuring continuous tissue regeneration and repair actions rather than a single brief intervention, thereby reducing recurrence
Solution Approach 2:
The invention uses a composite system combining hydrogel matrix with living mesenchymal stem cells. This composite material integrates the structural benefits of hydrogel (biocompatibility, controlled release) with the biological regenerative capabilities of stem cells, creating a synergistic treatment that improves reliability while maintaining minimally invasive benefits
4Adaptability or versatility
If autologous stem cells are used for treatment, then patient-specific compatibility is achieved, but multiple surgeries are required increasing patient discomfort
Solution Approach 1:
Mesenchymal stem cells are harvested, expanded, and encapsulated in hydrogel in advance before the treatment procedure. This preliminary preparation consolidates multiple steps into one surgical session, eliminating the need for repeated surgeries while maintaining patient-specific compatibility through autologous or pre-matched cell sources
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mesenchymal stem cell-hydrogel composition promotes effective healing of anal fistulas, reducing recurrence rates, minimizing tissue damage, and improving patient quality of life by providing a sustained release of stem cells and their secretions.
Implementation Method 1
All hydrophilic or water-soluble polymers can form hydrogels through physical or chemical cross-linking. Hydrogels possess a grid-like three-dimensional structure and can absorb large amounts of water, swelling without dissolving in it.
Implementation Method 2
Under specific induction conditions, both in vivo and in vitro, they can differentiate into various tissue cells such as adipocytes, osteocytes, chondrocytes, myocytes, tendons, ligaments, neurons, hepatocytes, cardiomyocytes, and endothelial cells.
Implementation Method 3
They can also delay the degradation of stem cells and their secretions within the body, creating a sustained release system that maintains an effective concentration of stem cells for a prolonged period, thereby enhancing therapeutic outcomes.
Implementation Method 4
The three-dimensional network formed by hydrogels can mimic the normal microenvironment of the body, providing a rough surface conducive to cell adhesion, differentiation, and proliferation.
Data Source
AI summary
Provided are a composition containing mesenchymal stem cells and a hydrogel, and the use thereof. The mesenchymal stem cells are dispersed in the hydrogel. In the composition, the mesenchymal stem cells cooperate with the hydrogel, such that the healing of a fistula can be effectively promoted, the surgical operation difficulty and frequency are greatly reduced and the wound surface is also reduced, the discomfort of a patient in the perioperative period is alleviated, the disease course is shortened, the cure rate is increased, and the recurrence rate is reduced.